Depressive Disorder

In this Assignment, you will become the “captain of the ship” as you provide treatment recommendations and identify medical management, community support resources, and follow-up plans for a client with a depression disorder.
Learning Objectives
Students will:

  • Recommend psychopharmacologic treatments based on   therapeutic endpoints for clients with depression disorders
  • Recommend psychotherapy based on therapeutic endpoints      for clients with depression disorders
  • Identify medical management needs for clients with      depression disorders
  • Identify community support resources for clients with      depression disorders
  • Recommend follow-up plans for clients with depression      disorders

To prepare for this Assignment:

  • Select an adult or older adult client with a depressive      disorder you have seen in your      practicum.

In 3–4 pages, write a treatment plan for your client in which you do the following:

  • Describe the HPI and clinical impression for the      client.
  • Recommend psychopharmacologic treatments and describe      specific and therapeutic endpoints for your psychopharmacologic agent.      (This should relate to HPI and clinical impression.)
  • Recommend psychotherapy choices (individual, family,      and group) and specific therapeutic endpoints for your choices.
  • Identify medical management needs, including primary      care needs, specific to this client.
  • Identify community support resources (housing,      socioeconomic needs, etc.) and community agencies that are available to      assist the client.
  • Recommend a plan for follow-up intensity and frequency      and collaboration with other providers.

Required Readings
Sadock, B. J., Sadock, V. A., & Ruiz, P. (2014). Kaplan & Sadock’s synopsis of psychiatry: Behavioral sciences/clinical psychiatry (11th ed.). Philadelphia, PA: Wolters Kluwer.
· Chapter 8, “Mood Disorders” (pp. 347–386)
Gabbard, G. O. (2014). Gabbard’s treatment of psychiatric disorders (5th ed.). Washington, DC: American Psychiatric Publications.
· Chapter 12, “Psychotherapy of Mood Disorders”
· Chapter 14, “Pharmacological and Somatic Treatments for Major Depressive Disorder”
American Psychiatric Association. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Washington, DC: Author.
· “Depressive Disorders”
· Major Depressive Disorder
· Persistent Depressive Disorder (dysthymia)
· Premenstrual Dysphoric Disorder
· Substance/Medication-Induced Depressive Disorder
· Depressive Disorder Due to Another Medical Condition
· Other Specified Depressive Disorder
· Unspecified Depressive Disorder
Stahl, S. M. (2017). Prescriber’s Guide: Stahl’s Essential Psychopharmacology (6th ed.). New York, NY: Cambridge University Press.
Grieve, S. M., Korgaonkar, M. S., Koslow, S. H., Gordon, E., Williams, L. M. (2013). Widespread reductions in gray matter volume in depression. NeuroImage: Clinical3, 332-339. doi:10.1016/j.nicl.2013.08.016
Lach, H. W., Chang, Y-P., & Edwards, D. (2010). Can older adults with dementia accurately report depression using brief forms? Reliability and validity of the Geriatric Depression Scale. Journal of Gerontological Nursing36(5), 30–37. doi:10.3928/00989134-20100303-01
Steffens, D. C., McQuoid, D. R., & Potter, G. G. (2014). Amnestic mild cognitive impairment and incident dementia and Alzheimer’s disease in geriatric depression. International Psychogeriatrics, 26(12), 2029–2036. doi:10.1017/S1041610214001446
Drug Enforcement Administration. (n.d.). Drug schedules. Retrieved June 14, 2016, from 
Required Media
Classroom Productions (Producer). (2015). Depressive Disorders [Video file]. San Luis Obispo, CA: Microtraining Associates.